Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma

SIMPLE SUMMARY: The incidence of the most common metastatic skin malignancy, cutaneous squamous cell carcinoma (cSCC), is growing worldwide, and the prognosis of the metastatic disease is poor. Presently, there are no biomarkers or therapeutic targets for high-risk cSCCs. Recent studies have demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmati Nezhad, Pegah, Riihilä, Pilvi, Knuutila, Jaakko S., Viiklepp, Kristina, Peltonen, Sirkku, Kallajoki, Markku, Meri, Seppo, Nissinen, Liisa, Kähäri, Veli-Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773783/
https://www.ncbi.nlm.nih.gov/pubmed/35053469
http://dx.doi.org/10.3390/cancers14020305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773783/
https://www.ncbi.nlm.nih.gov/pubmed/35053469
http://dx.doi.org/10.3390/cancers14020305

Ejemplares similares